Multidrug-Resistant Salmonella enterica 4,[5],12:i:- Sequence Type 34, New South Wales, Australia, 2016–2017

Multidrug- and colistin-resistant Salmonella enterica serotype 4,[5],12:i:- sequence type 34 is present in Europe and Asia. Using genomic surveillance, we determined that this sequence type is also endemic to Australia. Our findings highlight the public health benefits of genome sequencing–guided su...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnott, Alicia, Wang, Qinning, Bachmann, Nathan, Sadsad, Rosemarie, Biswas, Chayanika, Sotomayor, Cristina, Howard, Peter, Rockett, Rebecca, Wiklendt, Agnieszka, Iredell, Jon R., Sintchenko, Vitali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875280/
https://www.ncbi.nlm.nih.gov/pubmed/29553318
http://dx.doi.org/10.3201/eid2404.171619
Descripción
Sumario:Multidrug- and colistin-resistant Salmonella enterica serotype 4,[5],12:i:- sequence type 34 is present in Europe and Asia. Using genomic surveillance, we determined that this sequence type is also endemic to Australia. Our findings highlight the public health benefits of genome sequencing–guided surveillance for monitoring the spread of multidrug-resistant mobile genes and isolates.

Ejemplares similares